"Abbott Laboratories... will not pursue commercialization of its ZoMaxx(TM)Drug-Eluting Coronary Stent System."
Best of luck to everyone around the world who has been working on this program.
10/03/2006
Drug-eluting Stent News
"Abbott Laboratories... will not pursue commercialization of its ZoMaxx(TM)Drug-Eluting Coronary Stent System."
Best of luck to everyone around the world who has been working on this program.
Subscribe to:
Post Comments (Atom)
..................................
2 comments:
WOW!!! Did you first get word of this from the news report or from your boss??? Still working on dual drug stent??
Yahoo news had it 3 hours before it showed up onthe internal abbott site. And dual drug was basically cancelled a couple of weeks ago. Yes, it appears to be the end of stent for those of us in The Park.
Post a Comment